Intellectual Property as a Value Driver and Risk Factor in Life Sciences Venture Investment: A Ten-Issue Due Diligence Framework
Hidden Leverage in Plain Sight – Reassessing Mature Patent Value in the Current Enforcement Environment
TTAB Reminds Businesses That Trade Name Use Is Not Trademark Use, in Maple Leaf Cheesemakers Decision
Key Takeaways: How Regulatory Exclusivity, PTA, PTE, and Double Patenting Shape Pharmaceutical Lifecycle Value